≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Respiratory tuberculosis

DOID EFO Endpoint Browser PheWeb

TBC_RESP

pulmonary tuberculosis: A bacterial infection that affects the lungs and is caused by Mycobacterium tuberculosis. Most patients with tuberculosis do not have symptoms (latent tuberculosis) and are not contagious. When signs and symptoms occur (active tuberculosis), patients become contagious. The signs and symptoms include chronic cough with blood-tinged sputum, night sweats, fever, fatigue, and weight loss.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

2316

6. Filter based on genotype QC (FinnGen only)

2316

Control definitions (FinnGen only)

Control exclude
IBD_TUBERCULOSIS

Extra metadata

First used in FinnGen datafreeze
DF2

Similar endpoints

↥

List of similar endpoints to Respiratory tuberculosis based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 34910 13713 20113
Only index persons 17505 8163 9342
Unadjusted period prevalence (%)
Whole population 0.51 0.39 0.56
Only index persons 0.33 0.30 0.36
Median age at first event (years)
Whole population 53.02 52.55 53.15
Only index persons 42.73 41.60 43.72

-FinnGen-

Key figures

All Female Male
Number of individuals 2316 804 1512
Unadjusted period prevalence (%) 0.53 0.27 0.67
Median age at first event (years) 45.55 37.14 50.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2155
Matched controls
21549
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
01102
ICD-8 Finland
Pulmonary tuberculosis, Non cavernosa
+∞
323.0
372
*
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
+∞
294.7
276
*
01107
ICD-8 Finland
Pulmonary tuberculosis, Suspecta
+∞
260.8
245
*
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
+∞
209.9
198
*
01220
ICD-8 Finland
Other respiratory tuberculosis, Pleurisy with effusion without mention of cause
+∞
193.7
183
*
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
+∞
171.1
162
*
01101
ICD-8 Finland
Pulmonary tuberculosis, Cavernosa
+∞
143.3
136
*
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
39.4
121.1
154
42
01210
ICD-8 Finland
Other respiratory tuberculosis, Tuberculosis pleurae, pleuritis exsudativa tuberculosa
+∞
119.9
114
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.8
98.8
486
1532
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.2
94.7
406
1128
0110A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, BAKTER.VARMA]
+∞
78.6
75
*
0110K
ICD-8 Finland
NA
+∞
71.2
68
*
A70
ICPC
Tuberculosis
+∞
70.2
67
*
A15.2
ICD-10 Finland
Tuberculosis of lung, confirmed histologically
+∞
64.9
62
*
A16.2
ICD-10 Finland
Tuberculosis of lung, without mention of bacteriological or histological confirmation
+∞
60.7
58
*
0110X
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, EPÄILTY]
+∞
58.6
56
*
A16.5
ICD-10 Finland
Tuberculous pleurisy, without mention of bacteriological or histological confirmation
+∞
57.5
55
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.6
56.0
496
2240
A15.6
ICD-10 Finland
Tuberculous pleurisy, confirmed bacteriologically and histologically
+∞
50.2
48
*
A15.9
ICD-10 Finland
Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
+∞
47.0
45
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
46.5
803
4888
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
26.3
42.5
59
23
0110J
ICD-8 Finland
NA
+∞
41.8
40
*
A16.1
ICD-10 Finland
Tuberculosis of lung, bacteriological and histological examination not done
+∞
41.8
40
*
R03BB04
ATC
tiotropium bromide; inhalant
2.5
41.0
376
1701
A16.9
ICD-10 Finland
Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation
+∞
39.7
38
*
A15.3
ICD-10 Finland
Tuberculosis of lung, confirmed by unspecified means
+∞
34.5
33
*
0110A
ICD-8 Finland
NA
+∞
34.5
33
*
Y3409
ICD-8 Finland
Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis
18.1
34.1
53
30
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.0
34.0
217
787
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
33.8
506
2838
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
12.3
33.0
60
50
0120X
ICD-9 Finland
Other respiratory tuberculosis, Tuberculous pleurisy[TUBERCULOSIS PLEURAE, EPÄILTY]
+∞
32.4
31
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.5
31.7
159
486
A15.7
ICD-10 Finland
Primary respiratory tuberculosis, confirmed bacteriologically and histologically
+∞
30.3
29
*
0119X
ICD-9 Finland
Pulmonary tuberculosis, unspecified[TUBERCULOSIS PULMONUM NUD, EPÄILTY]
+∞
29.2
28
*
01104
ICD-8 Finland
Pulmonary tuberculosis, Tuberculoma pulmonum
+∞
29.2
28
*
0112A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung with cavitation[TUBERCULOSIS PULMONUM CAVERNOSA, BAKTERIOL.VARMA]
+∞
28.2
27
*
01106
ICD-8 Finland
Pulmonary tuberculosis, Pulmonum alia sive NUD
+∞
28.2
27
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
28.1
325
1621
1240
FHL
Bronchoscopy
5.4
27.6
85
163
R03DA04
ATC
theophylline; systemic, rectal
2.4
27.6
254
1135
H02AB06
ATC
prednisolone; systemic
1.7
27.0
977
7194
Z03.0
ICD-10 Finland
Observation for suspected tuberculosis
16.0
25.4
41
26
01297
ICD-8 Finland
Other respiratory tuberculosis, Suspecta
+∞
24.0
23
*
J01MA14
ATC
moxifloxacin; systemic
2.3
23.5
226
1032
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
23.2
352
1952
01109
ICD-8 Finland
Pulmonary tuberculosis, Unspecified
+∞
22.9
22
*
R03AC02
ATC
salbutamol; inhalant
1.6
22.6
944
7100
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
22.6
196
849
R03AC12
ATC
salmeterol; inhalant
2.6
22.5
168
669
R03BB01
ATC
ipratropium bromide; inhalant
2.4
22.1
198
871
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.2
21.8
251
1244
A15.8
ICD-10 Finland
Other respiratory tuberculosis, confirmed bacteriologically and histologically
+∞
20.9
20
*
J96.1
ICD-10 Finland
Chronic respiratory failure
3.5
20.7
100
298
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.8
20.1
130
475
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
19.6
146
578
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.8
19.2
131
495
TGC00
NOMESCO Finland
Bronchial lavation
3.7
19.2
85
236
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
8.8
17.9
38
44
J47
ICD-10 Finland
Bronchiectasis
4.0
17.8
72
185
1370A
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,TUBERKULOOSIARPI]
26.9
17.8
24
9
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
3.6
17.8
81
231
A15.4
ICD-10 Finland
Tuberculosis of intrathoracic lymph nodes, confirmed bacteriologically and histologically
+∞
17.7
17
*
0310A
ICD-9 Finland
Diseases due to other mycobacteria, Pulmonary
95.8
17.6
19
*
R04.2
ICD-10 Finland
Haemoptysis
2.8
17.1
113
419
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.0
16.0
94
325
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
15.3
347
2179
H02AB07
ATC
prednisone; oral
1.7
14.9
322
1994
51120
ICD-8 Finland
Pleurisy, Other specified forms of effusion, except tuberculous
25.2
14.7
20
8
01710
ICD-8 Finland
Tuberculosis of other organs, Lymphonodorum colli
+∞
14.6
14
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.1
14.0
75
244
J01FA06
ATC
roxithromycin; oral
1.5
14.0
749
5767
0118X
ICD-9 Finland
Pulmonary tuberculosis, Other specified pulmonary tuberculosis[TUBERCULOSIS PULMONUM ALIA, EPÄILTY]
+∞
13.6
13
*
0119A
ICD-9 Finland
Pulmonary tuberculosis, unspecified[TUBERCULOSIS PULMONUM NUD, BAKTERIOLOG. VARMA]
+∞
13.6
13
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
13.5
797
6250
J45.8
ICD-10 Finland
Mixed asthma
3.0
12.8
75
259
R03BA01
ATC
beclometasone; inhalant
1.7
12.8
283
1760
M05BA04
ATC
alendronic acid; oral
1.9
12.7
190
1038
0120B
ICD-9 Finland
Other respiratory tuberculosis, Tuberculous pleurisy[TUBERCULOSIS PLEURAE, HISTOLOGISESTI VARMENNETTU]
+∞
12.5
12
*
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
12.2
141
696
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.4
11.9
102
439
R03BA02
ATC
budesonide; inhalant
1.6
11.9
305
1975
B90.0
ICD-10 Finland
Sequelae of central nervous system tuberculosis
65.3
11.6
13
*
A18.2
ICD-10 Finland
Tuberculous peripheral lymphadenopathy
+∞
11.5
11
*
A02BA02
ATC
ranitidine; systemic
1.5
11.3
435
3105
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
11.2
834
6752
L04AX01
ATC
azathioprine; systemic
2.6
11.1
79
310
R03AC13
ATC
formoterol; inhalant
2.2
10.9
114
543
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
10.9
118
570
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.7
10.7
45
123
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.2
10.6
110
522
5111B
ICD-9 Finland
Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA ALIA DEFINITA]
60.3
10.6
12
*
03199
ICD-8 Finland
Other diseases due to Mycobacteria, Other and unspecified
+∞
10.4
10
*
0112X
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung with cavitation[TUBERCULOSIS PULMONUM CAVERNOSA, EPÄILTY]
+∞
10.4
10
*
01103
ICD-8 Finland
Pulmonary tuberculosis, Bronchialis
+∞
10.4
10
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.2
10.4
54
174
R03BB02
ATC
oxitropium bromide; inhalant
3.6
10.3
45
127
J01MA12
ATC
levofloxacin; systemic
1.5
10.0
387
2755
13599
ICD-8 Finland
Sarcoidosis, Unspecified
9.2
10.0
20
22
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.0
9.9
118
592
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
9.9
335
2315
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.7
9.8
27
48
01908
ICD-8 Finland
Late effects of tuberculosis, Sequelae aliae o tuberculosis organorum respirationis
20.1
9.8
14
7
Z20.1
ICD-10 Finland
Contact with and exposure to tuberculosis
9.6
9.8
19
20
A98
ICPC
Health maint/preventive medicine
0.7
9.7
1349
14938
R06.0
ICD-10 Finland
Dyspnoea
1.4
9.6
477
3573
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
9.5
189
1140
R05CB01
ATC
acetylcysteine; inhalant, oral
2.7
9.4
61
228
N05CD07
ATC
temazepam; oral
1.5
9.4
325
2260
A18.0
ICD-10 Finland
Tuberculosis of bones and joints
+∞
9.4
9
*
01292
ICD-8 Finland
Other respiratory tuberculosis, Lymphonodorum tracheobronchialium et mediastini
+∞
9.4
9
*
J43.9
ICD-10 Finland
Emphysema, unspecified
2.9
9.3
54
187
48609
ICD-8 Finland
Pneumonia, unspecified
3.7
9.3
39
107
51899
ICD-8 Finland
Bronchiectasis
8.3
9.1
19
23
A31.9
ICD-10 Finland
Mycobacterial infection, unspecified
36.8
9.0
11
*
J01AA02
ATC
doxycycline; systemic
1.3
9.0
1454
13099
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.1
9.0
48
159
XG410
NOMESCO Finland
Flow-volume spirometry
2.2
8.9
88
409
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
8.9
289
1977
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
4.4
8.9
31
72
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
8.8
87
404
A10BA02
ATC
metformin; oral
0.7
8.7
344
4599
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.6
8.4
59
232
A16.8
ICD-10 Finland
Other respiratory tuberculosis, without mention of bacteriological or histological confirmation
+∞
8.3
8
*
A18.1
ICD-10 Finland
Tuberculosis of genitourinary system
+∞
8.3
8
*
48601
ICD-8 Finland
More specifically, unspecified pneumonia and the pleural irritation caused by it
5.8
8.3
22
38
N02AX02
ATC
tramadol; systemic, rectal
1.3
8.3
783
6497
132
Kela drug reimbursment
Sarcoidosis
4.9
8.2
25
51
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
8.2
134
759
R95
ICPC
Chron obstructive pulmonary disease
2.3
7.9
68
299
P01BA02
ATC
hydroxychloroquine; oral
1.8
7.8
128
727
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
25.1
7.6
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.3
7.6
36
111
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
3.9
7.5
29
75
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.1
7.5
27
66
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
3.1
7.4
38
124
A07EC01
ATC
sulfasalazine; oral, rectal
1.8
7.4
132
770
0120A
ICD-9 Finland
Other respiratory tuberculosis, Tuberculous pleurisy[TUBERCULOSIS PLEURAE, BAKTERIOLOGISESTI VARMA]
+∞
7.3
7
*
01202
ICD-8 Finland
NA
+∞
7.3
7
*
A18.8
ICD-10 Finland
Tuberculosis of other specified organs
+∞
7.3
7
*
0110B
ICD-8 Finland
NA
+∞
7.3
7
*
48509
ICD-8 Finland
Bronchopneumonia, unspecified
3.7
7.2
29
79
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
7.1
515
4085
J46
ICD-10 Finland
Status asthmaticus
2.4
7.1
56
234
R03AC03
ATC
terbutaline; inhalant
1.5
7.0
230
1575
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
2.4
7.0
55
230
13597
ICD-8 Finland
Sarcoidosis, Suspecta
5.2
6.9
20
39
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
2.3
6.9
58
252
L04AA13
ATC
leflunomide; oral
2.7
6.9
45
171
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.8
6.8
41
149
N02AC04
ATC
dextropropoxyphene; oral
1.8
6.8
106
595
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.1
6.8
70
334
A06AD11
ATC
lactulose; oral
1.4
6.7
362
2734
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.5
147
2184
Y3498
ICD-8 Finland
Follow-up examination of illness, accident or surgery, Other illnesses, accidents or surgeries
10.0
6.5
12
12
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
2.6
6.5
44
173
H02AB04
ATC
methylprednisolone; systemic
1.5
6.5
251
1782
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
6.5
581
4751
A31.89
ICD-10 Finland
Other mycobacterial infections
70.0
6.4
7
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
7.4
6.4
14
19
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
4.9
6.3
19
39
A15.5
ICD-10 Finland
Tuberculosis of larynx, trachea and bronchus, confirmed bacteriologically and histologically
+∞
6.3
6
*
A15
ICD-10 Finland
Respiratory tuberculosis, bacteriologically and histologically confirmed
+∞
6.3
6
*
M49.0*A18.0
ICD-10 Finland
Tuberculosis of spine
+∞
6.3
6
*
A19.1
ICD-10 Finland
Acute miliary tuberculosis of multiple sites
+∞
6.3
6
*
0116A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculous pneumonia [any form][TUBERCULOSIS PULMONUM CUM PNEUMONIA,BAKTER.VARMA]
+∞
6.3
6
*
01105
ICD-8 Finland
Pulmonary tuberculosis, Disseminata pulmonum
+∞
6.3
6
*
A16.4
ICD-10 Finland
Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation
+∞
6.3
6
*
A18.3
ICD-10 Finland
Tuberculosis of intestines, peritoneum and mesenteric glands
+∞
6.3
6
*
0118A
ICD-9 Finland
Pulmonary tuberculosis, Other specified pulmonary tuberculosis[TUBERCULOSIS PULMONUM ALIA, BAKTERIOLOG.VARMA]
+∞
6.3
6
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
6.2
51
221
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
3.3
6.2
29
90
5188X
ICD-9 Finland
Other diseases of lung
5.0
6.2
18
36
Y0499
ICD-8 Finland
Investigation of respiratory system
2.9
6.1
35
123
5120A
ICD-9 Finland
Pneumothorax, Spontaneous tension pneumothorax
6.7
6.0
14
21
D86.0
ICD-10 Finland
Sarcoidosis of lung
3.4
6.0
26
76

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
309
668
5.18
136.46
6.3
2.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
155
217
7.58
105.83
9.9
3.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
150
401
3.93
49.44
2.6
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
100
261
3.96
34.02
6.4
2.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
124
424
3.03
27.75
1.8
1.6
iu/ml
1.7
13.2
0.42
44
92
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
85
235
3.72
26.67
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
94
290
3.34
24.97
1.5
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
31
36
8.71
24.55
1.8
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
300
1613
1.99
24.54
1.8
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
38
57
6.76
24.24
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
58
132
4.48
23.66
1.6
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
49
97
5.14
23.57
7.1
3.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
79
232
3.49
22.68
1.6
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
77
244
3.23
19.63
3.5
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
73
228
3.27
19.06
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
78
261
3.06
18.17
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
106
423
2.58
17.76
1.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
100
398
2.58
16.86
1.7
1.6
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
15
13
11.61
14.43
1.1
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
20
32
6.30
12.01
1.4
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
24
47
5.15
11.74
1.1
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
73
299
2.49
11.68
1.7
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1352
15167
0.74
11.01
5.2
5.2
mmol/l
2.6
2.6
0.09
1217
13606
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
50
175
2.90
10.88
1.3
1.3
u/l
28.6
15.2
2.26
44
163
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
25
55
4.58
10.71
1.3
2.6
u/ml
2191.3
36891.6
—
7
13
(44790047)
51
186
2.78
10.31
1.7
1.5
—
—
—
0
0
(44790049)
51
186
2.78
10.31
1.7
1.5
—
—
—
0
0
(44790048)
51
186
2.78
10.31
1.7
1.5
—
—
—
0
0
(44806118)
51
186
2.78
10.31
1.7
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
116
607
1.96
10.19
1.8
1.9
u/l
39.8
38.5
0.31
103
524
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
435
3222
1.43
9.65
2.1
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1321
14737
0.76
9.37
4.6
4.6
mmol/l
4.5
4.4
0.45
1191
13320
(4015189)
23
53
4.37
9.33
3.0
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
269
1825
1.54
9.25
2.0
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1544
16838
0.75
9.12
35.0
25.1
e9/l
249.5
240.2
5.40
1495
16244
(3010813) Leukocytes [#/volume] in Blood
1546
16850
0.75
9.04
35.0
25.1
e9/l
7.3
6.9
3.85
1493
16184
(3042936) Bacteria identified in Isolate by Culture
348
2502
1.46
9.01
2.5
2.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1546
16847
0.75
9.00
35.1
25.2
g/l
130.9
132.7
4.39
1513
16436
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
314
2213
1.48
9.00
7.2
6.8
kpa
5.1
5.1
0.39
299
2090
(3027801) Oxygen [Partial pressure] in Arterial blood
314
2213
1.48
9.00
7.2
6.8
kpa
11.4
11.6
0.24
300
2091
(3026361) Erythrocytes [#/volume] in Blood
1546
16844
0.75
8.96
34.9
25.1
e12/l
4.4
4.4
1.85
1490
16178
(3035941) MCH [Entitic mass]
1546
16843
0.75
8.95
34.8
24.9
pg
30.3
30.4
1.09
1511
16433
(3005719) IgG [Mass/volume] in Serum or Plasma
179
1111
1.66
8.94
2.9
2.7
g/l
10.3
10.8
0.73
168
1009
(3024731) MCV [Entitic volume]
1546
16842
0.75
8.94
34.8
25.0
fl
91.8
91.7
0.28
1511
16433
(3003396) Base excess in Arterial blood by calculation
314
2218
1.48
8.89
7.4
6.8
mmol/l
1.4
1.2
0.44
260
1695
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
316
2239
1.48
8.81
2.1
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1310
14565
0.77
8.62
4.6
4.6
mmol/l
1.4
1.4
0.97
1174
13028
(3019060) Gas panel - Arterial blood
205
1336
1.59
8.41
4.1
4.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
921
7797
1.30
8.38
8.8
5.4
e9/l
0.0
0.0
0.19
813
6634
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
313
2242
1.46
8.23
2.0
1.8
—
—
—
0
0
(4010399)
178
1130
1.62
8.14
1.5
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
48
194
2.51
8.00
1.7
1.7
g/l
0.8
0.9
0.12
33
149
(3001604) Monocytes [#/volume] in Blood
914
7765
1.29
7.99
8.8
5.4
e9/l
0.6
0.6
1.63
803
6601
(3013115) Eosinophils [#/volume] in Blood
943
8054
1.29
7.87
9.2
5.6
e9/l
0.2
0.2
0.27
843
6964
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
28
85
3.32
7.79
1.5
2.1
e6/l
754.4
563.0
0.41
23
72
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
42
163
2.61
7.61
1.7
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1364
14992
0.78
7.58
4.9
4.9
mmol/l
6.0
6.1
0.76
1216
13278
(3037522) Nuclear Ab [Titer] in Serum
250
1744
1.49
7.51
1.3
1.3
titre
549.4
488.7
0.21
53
387
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1273
14098
0.78
7.46
4.1
4.1
mmol/l
1.3
1.3
0.01
1129
12502
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
41
159
2.61
7.45
1.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
41
159
2.61
7.45
1.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
41
159
2.61
7.45
1.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
55
245
2.28
7.42
1.8
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1449
15782
0.78
7.29
21.7
16.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
43
173
2.51
7.26
1.7
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
121
717
1.73
7.21
1.5
1.2
u/ml
215.5
231.3
0.08
108
652
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
51
223
2.32
7.19
1.3
1.3
u/l
473.5
335.6
0.88
46
212
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
56
255
2.23
7.18
1.5
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
68
336
2.05
7.10
1.4
1.5
g/l
37.3
31.1
2.92
63
300
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
46
194
2.40
7.04
1.9
1.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1502
16257
0.78
6.96
27.9
20.3
umol/l
85.7
85.2
0.16
1502
16249
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
311
4115
0.72
6.76
2.9
3.2
ug/l
0.9
0.8
0.16
209
2887
(3028026) IgM [Mass/volume] in Serum or Plasma
141
886
1.63
6.75
1.9
1.8
g/l
1.5
1.5
0.07
130
797
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
28
94
3.00
6.65
1.6
2.1
e6/l
641.1
674.6
0.07
14
38
(3019198) Lymphocytes [#/volume] in Blood
921
7959
1.26
6.65
8.9
5.5
e9/l
2.0
1.9
0.30
819
6895
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
13
25
5.22
6.49
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
18
6.14
6.43
2.3
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
659
5488
1.28
6.42
9.3
5.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
50
229
2.21
6.36
1.4
1.5
mmol/l
5.8
6.5
0.82
45
215
(3016502) Oxygen saturation in Arterial blood
271
1988
1.41
6.23
7.9
7.1
%
94.9
95.1
0.25
259
1909
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
472
5805
0.77
6.16
4.0
4.6
%
21.8
22.0
0.07
237
3001
(3011412) CD3 cells [#/volume] in Blood
32
122
2.65
6.06
1.6
2.0
e9/l
1.7
1.0
0.73
13
72
(3023103) Potassium [Moles/volume] in Serum or Plasma
1518
16322
0.80
6.05
28.0
20.6
mmol/l
4.0
4.0
0.09
1480
15767
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
12
23
5.24
6.01
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
91
526
1.76
5.97
1.6
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1516
16292
0.80
5.94
27.8
20.4
mmol/l
139.4
139.6
2.73
1481
15765
(3007853) Bacteria identified in Skin by Aerobe culture
264
1946
1.40
5.90
2.1
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
361
2804
1.34
5.82
4.2
3.0
mmol/l
0.8
0.8
0.59
332
2585
(3019069) Monocytes/100 leukocytes in Blood
854
7405
1.24
5.76
9.8
6.0
%
9.0
8.9
0.22
804
6850
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
613
7235
0.79
5.62
4.5
5.3
ug/l
4.2
4.4
0.05
530
6343
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
71
388
1.86
5.62
1.6
2.0
mg/l
10.9
13.4
0.91
62
354
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
25
88
2.86
5.51
1.6
1.3
u/ml
1.5
0.7
0.32
19
51
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1320
14351
0.81
5.51
6.2
6.4
mmol/mol
40.5
40.9
0.76
1194
12980
(3022096) Basophils/100 leukocytes in Blood
826
7173
1.24
5.41
9.4
5.7
%
0.7
0.6
0.18
777
6621
(40768806) Pleura Pathology biopsy report
52
259
2.03
5.39
1.4
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1517
16231
0.81
5.27
14.9
10.9
u/l
25.4
25.3
0.01
1456
15473
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
69
3.06
5.22
1.6
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
69
3.06
5.22
1.6
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
353
4423
0.76
5.18
2.9
3.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
26
97
2.70
5.17
1.5
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
26
97
2.70
5.17
1.5
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
26
97
2.70
5.17
1.5
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
849
7422
1.23
5.16
9.1
5.6
%
58.3
58.7
0.43
798
6864
(3006504) Eosinophils/100 leukocytes in Blood
844
7375
1.23
5.15
9.4
5.7
%
2.8
2.8
0.19
790
6799
(3002030) Lymphocytes/100 leukocytes in Blood
862
7550
1.23
5.14
9.5
5.9
%
25.9
25.9
0.02
805
6947
(4062490)
30
121
2.50
5.12
2.1
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
241
1792
1.38
5.12
8.5
7.6
g/l
119.9
119.9
0.01
232
1725
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1328
14379
0.82
5.08
22.4
16.3
ml/min/173m2
74.6
73.3
1.23
1121
11873
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
71
2.98
4.98
1.6
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
644
5496
1.24
4.86
6.3
4.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
29
119
2.46
4.80
2.1
1.3
g/l
7.6
7.1
0.28
23
82
(3024139) IgG subclass 3 [Mass/volume] in Serum
29
119
2.46
4.80
2.1
1.3
g/l
0.5
0.4
0.26
22
82
(3028192) IgG subclass 2 [Mass/volume] in Serum
29
119
2.46
4.80
2.1
1.3
g/l
2.6
2.8
0.27
21
83
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
73
2.89
4.76
1.6
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
25
96
2.62
4.73
1.7
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
987
8820
1.21
4.68
8.3
6.0
umol/l
10.6
12.4
6.98
941
8309
(3021879) Hepatitis B virus core Ab [Presence] in Serum
124
828
1.53
4.66
1.6
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
38
3.70
4.64
1.8
2.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
97
2.59
4.64
1.7
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
25
97
2.59
4.64
1.5
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
43
3.50
4.61
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
173
1244
1.42
4.49
8.4
7.0
mmol/l
24.9
24.5
0.73
163
1165
(3023199) Leukocytes [#/volume] in Pleural fluid
55
302
1.84
4.36
1.4
1.4
e6/l
1859.5
1760.3
0.11
37
219
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
66
2.89
4.33
1.1
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1013
9119
1.20
4.33
12.4
8.5
e9/l
4.4
4.3
0.44
902
7886
(3002179) Metamyelocytes/100 leukocytes in Blood
168
1210
1.42
4.33
5.2
3.8
%
0.5
0.7
0.66
42
302
(3012441) Differential panel - Pleural fluid
48
255
1.90
4.22
1.5
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
335
2694
1.28
4.17
2.8
2.4
g/l
2.2
2.3
1.34
309
2456
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
142
1002
1.44
4.10
9.2
8.3
mmol/l
24.3
24.3
0.01
133
912
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
32
148
2.18
4.09
1.3
1.1
u/ml
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
71
431
1.67
4.01
2.0
2.3
g/l
119.6
127.1
1.72
48
320
(3003458) Phosphate [Moles/volume] in Serum or Plasma
306
2447
1.29
3.98
6.1
5.2
mmol/l
1.1
1.0
2.19
277
2227
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
118
2.30
3.94
1.7
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1250
13463
0.84
3.91
26.1
18.5
%
38.3
38.6
0.33
753
8415
(3017181) Myelocytes/100 leukocytes in Blood
183
1368
1.37
3.81
5.2
3.9
%
0.7
0.9
0.67
67
442
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
278
2211
1.29
3.77
4.0
3.9
u/l
238.8
248.9
0.60
261
2066
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
124
868
1.45
3.76
2.0
1.9
ug/l
2.0
2.3
0.11
107
746
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
565
4869
1.21
3.75
3.8
3.1
u/l
35.5
35.4
0.02
531
4602
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
183
1372
1.36
3.74
1.8
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
74
463
1.62
3.74
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
74
463
1.62
3.74
1.6
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
53
303
1.77
3.73
5.0
5.2
iu/ml
499.1
813.6
—
8
42
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
314
2547
1.27
3.64
2.9
2.5
%
21.3
21.9
0.32
263
2137
(40758558) Short blood count panel - Blood
471
4000
1.22
3.61
9.1
6.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
171
1279
1.36
3.56
1.9
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1302
13910
0.85
3.45
4.9
4.6
mu/l
1.9
2.1
1.56
1160
12358
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
23
100
2.31
3.43
1.7
2.6
%
39.0
37.9
—
8
35
(3028308) Erythrocytes [#/volume] in Pleural fluid
48
275
1.76
3.39
1.4
1.4
e6/l
30283.0
71047.0
0.83
28
166
(3022948) Iron [Moles/volume] in Serum or Plasma
352
2920
1.24
3.37
2.8
2.5
umol/l
11.4
12.1
0.97
332
2663
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
176
1335
1.34
3.36
1.9
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
30
147
2.05
3.36
1.6
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
46
261
1.78
3.35
1.2
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
89
2.37
3.32
1.6
1.9
%
16.6
15.3
0.12
12
38
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
21
89
2.37
3.32
1.7
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
216
1692
1.31
3.30
6.7
6.3
mmol/l
11.7
11.3
0.35
205
1590
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
24
109
2.21
3.25
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
169
1282
1.34
3.24
5.4
4.0
%
0.1
0.1
0.12
62
403
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
43
242
1.79
3.23
8.3
6.4
mg/l
13.8
12.3
1.22
37
224
(3000492) Spirometry study
162
1224
1.35
3.19
1.5
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
137
1011
1.38
3.13
3.3
3.2
e9/l
3.9
4.3
0.62
89
739
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
243
1948
1.28
3.12
3.2
3.8
ug/l
58.5
20.9
0.54
204
1632
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
132
979
1.37
2.95
8.5
9.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1156
12374
0.87
2.88
32.2
22.7
g/l
330.4
331.4
3.29
1140
12184
(3004809) Band form neutrophils/100 leukocytes in Blood
52
321
1.63
2.85
3.3
3.7
%
1.0
1.7
1.06
40
242
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1480
15536
0.87
2.67
26.2
17.4
mg/l
27.8
27.6
0.07
1284
12712
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
153
1181
1.32
2.65
4.0
3.7
mmol/l
2.0
1.9
0.02
114
864
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
63
418
1.52
2.58
2.2
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
384
3301
1.20
2.58
2.0
1.6
mg/l
1.3
1.4
0.27
299
2558
(3020682) Albumin/Creatinine [Ratio] in Urine
481
5445
0.85
2.50
3.7
3.9
mg/mmol
14.1
9.1
0.85
301
3473
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
413
3584
1.19
2.49
4.9
4.1
ng/l
452.6
310.5
0.49
349
3058
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
16
69
2.33
2.48
1.4
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1157
12306
0.88
2.43
29.3
20.8
%
14.1
13.9
5.05
1138
11950
(3012516) Albumin [Mass/volume] in Urine
451
5120
0.85
2.42
3.1
3.2
mg/l
412.6
298.0
0.24
291
3291
(1616796) Gas panel - Central venous blood
64
433
1.49
2.41
3.8
4.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
225
1847
1.24
2.40
4.6
3.4
kpa
5.8
5.8
0.15
218
1776
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
38
227
1.69
2.40
1.2
1.3
u/ml
118.0
130.3
—
9
44
(3044889) 12 lead EKG panel
1054
11267
0.88
2.37
4.8
4.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
40
244
1.65
2.35
1.6
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
151
1185
1.29
2.35
5.7
4.1
%
0.0
0.4
0.79
48
328
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
206
1.71
2.34
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
156
1231
1.29
2.33
4.1
3.7
ph
7.4
7.4
2.02
19
148
(3014111) Lactate [Moles/volume] in Serum or Plasma
201
1636
1.25
2.32
8.3
6.1
mmol/l
1.4
1.4
0.34
192
1554
(3015235) Bicarbonate [Moles/volume] in Capillary blood
76
537
1.43
2.31
3.1
3.4
mmol/l
24.8
25.1
0.20
70
465
(3000991) Gas panel - Venous blood
193
1566
1.25
2.29
9.7
7.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
204
1666
1.25
2.29
2.2
2.6
g/l
66.1
66.0
0.13
178
1497
(3004716) Salmonella sp identified in Stool by Organism specific culture
83
597
1.40
2.29
1.5
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
298
2532
1.20
2.28
1.6
1.5
g/l
2.9
2.7
0.66
185
1482
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
154
1217
1.28
2.27
1.8
1.7
—
—
—
0
0
(4035726)
173
1392
1.26
2.22
1.4
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
157
1249
1.28
2.21
4.2
3.7
kpa
5.1
5.2
0.42
148
1139
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
16
73
2.20
2.21
3.0
2.5
u/ml
1313.7
1420.8
0.07
16
73
(3017446) Testosterone [Moles/volume] in Serum or Plasma
84
1141
0.73
2.21
1.9
2.1
nmol/l
11.8
12.0
0.05
71
973
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
57
385
1.49
2.19
2.0
1.5
g/l
0.2
0.2
0.22
57
366
(3000093) Morphology [Interpretation] in Blood Narrative
30
173
1.74
2.17
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
222
1842
1.23
2.17
4.7
3.4
mmol/l
2.0
2.0
0.03
172
1435
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
97
730
1.34
2.06
2.3
2.6
u/ml
0.3
0.3
0.71
52
423
(3035320) C reactive protein [Mass/volume] in Body fluid
21
110
1.92
2.05
3.4
2.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
66
466
1.43
2.05
1.2
1.2
u/ml
1.2
0.9
0.17
12
36
(40761535) Cells panel - Urine sediment
184
1509
1.24
2.02
3.9
3.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
26
3.08
2.01
1.1
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
58
402
1.45
1.99
3.0
3.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
463
0.60
1.98
1.4
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
21
3.34
1.96
1.0
1.3
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
11
4.55
1.94
1.0
1.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
11
4.55
1.94
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
322
1.50
1.94
1.6
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
52
747
0.69
1.93
1.5
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
196
1628
1.22
1.92
2.2
2.1
g/l
0.2
0.2
0.00
184
1500
(3009508) Creatinine [Moles/volume] in Urine
470
5233
0.87
1.91
3.3
3.1
mmol/l
7.0
7.3
0.71
388
4292
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
532
4800
1.14
1.91
2.5
2.2
mg/l
3.0
3.1
0.31
450
4014
(3014576) Chloride [Moles/volume] in Serum or Plasma
275
2361
1.19
1.90
9.0
6.3
mmol/l
103.9
104.3
0.77
270
2288
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
51
349
1.47
1.88
1.5
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
65
2.16
1.88
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
65
2.16
1.88
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
65
2.16
1.88
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
65
2.16
1.88
1.4
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
28
2.86
1.86
1.1
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
28
2.86
1.86
6.0
5.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
211
1775
1.21
1.83
2.7
2.5
ug/l
5.0
6.6
1.58
172
1506
(3043409) Potassium [Moles/volume] in Arterial blood
80
597
1.35
1.82
5.7
3.9
mmol/l
3.8
3.9
0.94
75
546
(40765089) Chromosome analysis panel - Blood by G-banded
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
41
270
1.53
1.82
1.5
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
73
2.06
1.80
1.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
23
3.05
1.80
1.0
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
20
109
1.84
1.77
1.3
1.1
titre
250.0
143.2
—
6
19
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
19
102
1.87
1.76
1.1
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
102
1.87
1.76
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
19
102
1.87
1.76
1.1
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
67
2.10
1.76
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
67
2.10
1.76
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
305
1.48
1.75
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
30
185
1.63
1.75
1.3
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
95
1.90
1.75
7.8
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
258
0.50
1.74
1.4
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
61
439
1.40
1.74
1.2
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
32
201
1.60
1.74
4.0
3.5
%
50.1
57.4
0.74
21
127
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
209
1.59
1.74
4.8
4.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
155
1.69
1.72
1.2
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
24
2.92
1.72
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
60
432
1.40
1.71
1.3
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
575
5250
1.13
1.71
2.8
2.5
u/l
58.4
58.0
0.09
533
4805
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
111
878
1.28
1.70
6.2
3.4
mmol/l
24.3
24.1
0.44
98
776
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
214
1818
1.20
1.69
3.9
3.1
ng/l
226.5
272.8
1.05
196
1672
(42529406) Shigella sp [Presence] in Stool by Culture
61
442
1.39
1.68
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
119
1.77
1.66
2.3
2.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
19
3.16
1.66
1.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
31
2.59
1.66
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
157
1.66
1.65
5.9
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
110
1376
0.79
1.65
5.0
4.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
355
3148
1.15
1.65
6.2
4.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
69
2.04
1.64
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
60
436
1.39
1.64
1.2
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
937
8808
1.11
1.63
8.1
6.7
mmol/l
1.2
1.2
0.11
791
7316
(3016650) Hepatitis A virus Ab [Presence] in Serum
33
213
1.56
1.62
1.1
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
56
2.15
1.61
1.3
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
56
2.15
1.61
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
114
1.76
1.56
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
339
3009
1.15
1.56
3.3
2.9
e6/l
1.4
1.3
0.22
214
1775
(3047181) Lactate [Moles/volume] in Blood
78
597
1.32
1.54
5.3
6.7
mmol/l
1.5
1.4
0.21
70
529
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
13
64
2.04
1.54
1.2
1.3
ug/l
2.0
55.8
—
6
30
(3024471) HLA-A [Type]
8
33
2.43
1.53
1.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
45
315
1.44
1.53
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
26
161
1.62
1.52
1.1
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
21
2.86
1.50
10.2
13.0
mmol/l
5.4
5.8
—
6
21
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
51
2.16
1.50
2.7
2.1
ug/l
17.5
177.7
0.48
11
43
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
36
242
1.50
1.50
1.7
1.9
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
36
242
1.50
1.50
8.1
8.8
mmol/l
7.4
7.6
0.09
30
202
(3013512) EKG study
478
5236
0.89
1.49
5.0
4.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
14
72
1.95
1.48
2.1
4.2
%
63.0
53.5
0.86
14
66
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
14
72
1.95
1.48
9.1
5.9
u/ml
50.6
68.3
—
5
18
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
30
194
1.55
1.48
3.4
2.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
132
1.67
1.46
1.7
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
20
117
1.72
1.45
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
205
1762
1.18
1.44
2.4
2.4
e9/l
65.0
68.1
0.82
158
1374
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
345
3846
0.88
1.43
1.3
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
59
2.04
1.43
1.5
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
212
1.52
1.43
1.1
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
31
204
1.53
1.43
5.2
1.7
—
—
—
0
0
(3039000) Anion gap in Blood
57
423
1.36
1.41
4.8
7.8
mmol/l
11.6
11.4
0.13
52
382
(3018572) Chloride [Moles/volume] in Blood
57
423
1.36
1.41
4.8
7.8
mmol/l
103.6
105.5
1.85
52
382
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
96
1.78
1.39
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
68
520
1.32
1.38
1.5
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
31
206
1.51
1.38
5.2
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
32
215
1.50
1.35
1.3
1.3
miu/ml
85.3
202.9
1.90
13
81
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
42
298
1.42
1.35
1.4
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
17
97
1.76
1.35
5.6
2.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
38
0.00
1.34
0.0
1.1
—
0.7
—
0
21
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
851
8024
1.10
1.34
7.4
5.9
mmol/l
1.2
1.2
0.28
754
7152
(3024354) Oxygen [Partial pressure] in Venous blood
178
1523
1.18
1.34
3.8
2.8
kpa
4.3
4.5
0.48
170
1457
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
102
826
1.25
1.34
2.2
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
23
144
1.60
1.32
1.4
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
113
1.69
1.31
2.0
3.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
815
7679
1.09
1.30
5.4
4.7
g/l
33.9
34.5
2.06
733
7044
(3016879) Cocaine [Presence] in Urine
29
193
1.51
1.29
5.4
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
44
2.05
1.26
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
97
788
1.24
1.25
6.2
4.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
203
1.48
1.25
5.3
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
644
6013
1.10
1.24
3.7
3.2
ng/l
2179.6
1956.1
0.51
567
5154
(4198724)
6
25
2.40
1.24
3.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
49
2.05
1.22
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
33
230
1.44
1.19
1.6
1.3
iu/l
23.9
26.4
0.20
27
191
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
26
2.31
1.18
1.7
1.3
umol/l
74.7
51.3
—
6
26
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
46
341
1.36
1.18
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
75
596
1.27
1.18
1.4
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1081
11277
0.92
1.17
4.0
3.8
pmol/l
15.1
15.1
0.37
956
9955
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
50
2.00
1.16
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
749
7062
1.09
1.16
4.6
4.3
ng/l
40.1
59.7
1.75
562
5409
(3035637) Corticotropin [Mass/volume] in Plasma
25
166
1.51
1.15
1.2
1.5
—
—
—
0
0
(3036489) Thrombin time
69
545
1.27
1.15
3.0
1.9
s
21.1
21.6
0.39
62
494
(3022621) pH of Urine by Test strip
96
1162
0.82
1.14
4.3
3.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
65
1.85
1.13
1.2
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
58
1.90
1.12
1.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
40
2.00
1.12
1.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
31
2.26
1.10
1.1
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
240
2137
1.14
1.10
1.3
1.2
u/ml
16.5
14.2
0.19
87
768
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
66
1.82
1.09
1.7
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
81
1.73
1.09
1.1
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
176
1536
1.16
1.08
2.7
2.3
u/l
31.9
36.4
0.96
146
1299
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
706
7471
0.92
1.07
2.3
2.1
pmol/l
90.4
92.3
0.46
382
3940
(40768797) Stomach Pathology biopsy report
240
2143
1.13
1.06
1.3
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
454
4202
1.10
1.05
5.3
3.9
%
87.7
83.8
2.75
442
4092
(3011397) Hemoglobin [Presence] in Urine by Test strip
404
3718
1.10
1.05
4.3
3.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
129
1.56
1.05
10.6
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
108
907
1.20
1.05
4.3
3.7
—
—
—
0
0
(4027681)
12
67
1.80
1.04
1.6
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
190
1674
1.15
1.03
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
80
653
1.23
1.03
1.8
1.8
—
—
—
0
0
(3035880) pH of Pleural fluid
21
138
1.53
1.03
1.3
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1215
11723
1.08
1.02
6.2
4.1
mm/h
16.9
14.5
4.43
1121
10675
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
47
1.92
1.02
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
115
977
1.19
0.99
1.5
1.7
g/l
1.5
1.6
0.63
100
828
(3007930) Methemoglobin/Hemoglobin.total in Blood
95
794
1.20
0.98
4.7
5.6
%
0.9
0.9
0.00
90
748
(4212803)
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1306
12651
1.07
0.97
10.6
7.5
u/l
79.0
81.3
0.92
1222
11771
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
241
2168
1.12
0.96
9.6
8.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
567
5324
1.09
0.96
2.4
2.2
u/l
233.2
244.0
0.11
525
4950
(3000850) Epithelial cells [#/volume] in Urine
421
3902
1.10
0.96
3.3
2.7
e6/l
5.7
4.7
0.88
376
3446
(21494434) Karyotype in Bone marrow
27
191
1.42
0.94
1.2
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
9
51
1.77
0.94
37.6
17.7
nmol/l
1515.7
1528.0
—
9
51
(3025941) Bacteria identified in Stool by Culture
94
789
1.20
0.94
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
247
2229
1.12
0.94
1.4
1.2
iu/ml
68.4
38.8
0.74
75
719
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
217
1.39
0.93
1.6
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
264
2393
1.12
0.93
2.5
2.4
%
1.8
1.8
0.14
227
2085
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
135
1171
1.16
0.92
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
384
4145
0.91
0.92
4.6
3.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
384
0.73
0.91
1.4
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
28
2.15
0.91
1.7
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
78
1.67
0.91
1.7
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
358
3875
0.91
0.91
1.6
1.6
mmol/l
1.3
1.3
0.07
311
3179
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
86
1.63
0.91
1.0
1.0
u/ml
2.2
2.3
—
5
31
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
193
1.40
0.90
1.6
1.9
—
—
—
0
0
(3015736) pH of Urine
644
6096
1.08
0.89
4.1
3.7
—
5.9
—
0
7
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
90
757
1.20
0.89
2.0
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
28
202
1.39
0.89
4.6
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
48
377
1.28
0.88
1.8
2.7
umol/l
31.3
34.8
0.32
38
310
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
95
1.58
0.87
1.5
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
95
1.58
0.87
1.5
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
95
1.58
0.87
1.5
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
41
316
1.30
0.87
1.6
1.4
e6/l
25.8
640.7
1.11
33
261
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
41
316
1.30
0.87
1.6
1.3
e6/l
32.2
37.3
0.08
31
249
(3036048) Francisella tularensis Ab [Titer] in Serum
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
556
5240
1.08
0.86
5.0
3.9
ph
7.4
7.4
0.13
96
1002
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
44
1.82
0.86
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
44
1.82
0.86
1.6
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
96
1.57
0.84
1.5
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
96
1.57
0.84
1.5
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
96
1.57
0.84
1.5
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
45
1.78
0.84
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
8
45
1.78
0.84
1.9
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
71
588
1.21
0.84
1.8
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
19
129
1.48
0.83
1.0
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
87
736
1.19
0.82
4.7
4.0
mmol/l
24.8
24.9
0.10
79
665
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
81
681
1.20
0.82
2.5
2.2
ug/l
286.8
495.3
1.30
75
636
(40768800) Prostate Pathology biopsy report
35
455
0.77
0.82
1.1
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
94
802
1.18
0.81
4.6
5.5
%
1.7
1.6
0.35
89
754
(21494814) CD8 cells/100 lymphocytes in Specimen
8
47
1.70
0.80
2.1
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
122
1.48
0.80
1.5
1.5
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
25
0.00
0.79
0.0
1.2
—
6.6
—
0
14
(3014051) Protein [Presence] in Urine by Test strip
30
395
0.76
0.78
3.1
2.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
82
1.59
0.78
1.2
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
21
148
1.42
0.77
1.3
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
54
439
1.24
0.77
5.5
5.0
mmol/l
3.3
2.7
0.71
39
304
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
725
7579
0.94
0.77
5.1
4.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
174
1.38
0.76
1.5
1.2
u/ml
3.3
3.5
0.03
12
57
(21494755) Public health laboratory ask at order entry panel
54
659
0.82
0.76
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
29
381
0.76
0.75
2.6
1.8
mg/l
12.3
3.1
0.57
21
293
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
1.6
1.5
ng/l
82.9
141.4
—
5
24
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
19
133
1.43
0.73
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
76
644
1.19
0.73
3.8
2.9
g/l
0.3
0.3
0.38
36
254
(3019977) pH of Arterial blood
17
117
1.46
0.71
7.5
2.9
ph
7.4
7.4
—
8
38
(3023420) DNA double strand Ab [Units/volume] in Serum
17
117
1.46
0.71
1.8
1.3
—
32.3
—
0
7
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
40
1.75
0.71
2.6
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
256
1.29
0.70
1.1
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
20
143
1.40
0.70
1.4
1.5
u/ml
29.8
30.4
—
5
28
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
221
1.32
0.69
1.2
1.2
u/ml
310.2
277.7
0.17
21
122
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
58
1.55
0.69
1.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
93
1.51
0.69
3.9
2.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
10
61
1.64
0.68
1.1
1.8
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
93
0.54
0.67
1.4
1.4
nmol/l
0.8
1.1
—
5
68
(3022145) Colonoscopy Study observation
180
1634
1.11
0.67
1.3
1.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
28
1.79
0.66
4.2
2.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
78
1.54
0.65
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
44
1.59
0.65
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
15
103
1.46
0.65
1.0
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1075
11058
0.95
0.64
6.1
5.0
e6/l
6114.9
2006.5
0.46
27
211
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
189
2066
0.91
0.63
4.5
4.7
%
32.1
33.1
0.55
112
1326
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
31
243
1.28
0.62
2.1
2.3
mg/l
26.6
24.7
—
9
59
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
150
1354
1.12
0.62
1.9
1.7
%
1.7
1.6
1.15
129
1126
(3050129) First trimester maternal screen panel - Serum or Plasma
12
79
1.52
0.62
1.8
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
104
1.45
0.62
1.1
1.3
mmol/l
15.1
11.1
—
6
30
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
71
1.55
0.62
1.7
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
63
1.59
0.61
1.1
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
20
0.00
0.60
0.0
1.6
—
8.0
—
0
12
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
2.3
—
0.6
—
0
14
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
204
1877
1.10
0.59
2.6
2.6
umol/l
6.1
10.2
5.60
173
1650
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
22
0.00
0.59
0.0
2.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
22
0.00
0.59
0.0
1.2
—
1.8
—
0
22
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
670
6438
1.06
0.59
2.4
2.2
nmol/l
79.9
78.5
0.55
582
5577
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
157
1.34
0.59
1.4
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
97
1.45
0.59
1.4
2.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
166
1.33
0.58
1.5
1.2
u/ml
2.3
5.1
1.03
11
72
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
0.5
—
0
7
(3000330) Specific gravity of Urine by Test strip
87
989
0.87
0.58
4.1
3.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
142
1285
1.11
0.58
3.7
2.9
ml/min/173m2
56.8
61.1
0.85
70
552
(3021589) Normoblasts [#/volume] in Blood
708
6819
1.06
0.57
14.4
10.2
e9/l
0.0
0.0
0.04
574
5517
(40757373) Influenza virus identified in Isolate
8
54
1.48
0.57
2.5
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
561
5369
1.06
0.57
3.3
2.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
30
238
1.26
0.56
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
777
7506
1.05
0.56
2.7
2.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
147
1337
1.11
0.55
2.1
2.1
nmol/l
363.9
374.7
0.31
130
1197
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
306
2875
1.07
0.55
3.6
3.1
e6/l
2.2
1.9
0.37
179
1648
(3032080) INR in Blood by Coagulation assay
790
7641
1.05
0.54
11.2
11.2
inr
1.3
1.4
1.27
204
2081
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
29
231
1.26
0.54
1.4
2.2
u/ml
41.3
195.7
0.42
29
223
(3045142) Bone marrow Pathology biopsy report
26
205
1.27
0.52
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
122
1347
0.90
0.52
1.5
1.6
—
—
—
0
0
(4094501)
33
403
0.82
0.52
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
60
519
1.16
0.50
5.4
4.6
ph
7.4
7.4
0.82
50
430
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
151
1385
1.10
0.49
3.7
3.6
ng/l
89.9
96.5
0.48
129
1167
(3022217) INR in Platelet poor plasma by Coagulation assay
273
2899
0.93
0.49
27.8
28.8
inr
1.5
1.5
0.15
39
389
(3003181) Sodium [Moles/volume] in Urine
40
335
1.20
0.48
1.6
1.3
mmol/l
54.2
61.5
0.71
33
265
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
128
1.33
0.47
1.2
1.1
u/ml
0.5
1.2
—
5
46
(3000570) Elastase.pancreatic [Mass/mass] in Stool
54
466
1.16
0.47
1.5
1.5
ug/g
262.7
272.7
0.13
35
280
(3032057) Clostridioides difficile [Presence] in Stool
7
48
1.46
0.46
2.3
2.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
26
209
1.25
0.46
1.1
1.1
iu/ml
192.5
75.9
—
6
35
(3004616) Nuclear Ab [Presence] in Serum
23
182
1.27
0.46
1.3
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
103
931
1.11
0.46
4.1
2.4
%
1.3
1.2
1.10
103
925
(4211845)
5
82
0.61
0.45
1.6
3.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
83
0.60
0.45
2.8
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
81
723
1.12
0.45
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
466
4473
1.05
0.44
3.3
2.9
umol/l
2691.3
7296.7
1.87
389
3785
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
39
459
0.85
0.44
2.0
2.3
ug/min
109.8
102.3
0.04
22
273
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
202
1.24
0.43
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
202
1.24
0.43
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
370
3532
1.06
0.43
5.3
4.4
kg/l
1.0
1.0
0.11
62
560
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
166
1.27
0.43
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
47
405
1.16
0.43
2.8
2.6
%
14.7
15.8
1.02
29
208
(44813793)
11
78
1.41
0.43
1.2
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
31
1.61
0.43
23.2
7.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
24
295
0.81
0.42
3.0
2.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
92
0.65
0.42
2.8
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
92
0.65
0.42
2.8
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
203
1.23
0.42
1.3
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.0
—
0.2
—
0
5
(3015377) Calcium [Moles/volume] in Serum or Plasma
609
5895
1.04
0.41
3.4
3.3
mmol/l
2.3
2.3
0.62
518
5005
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
16
0.00
0.41
0.0
1.1
—
0.2
—
0
9
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1101
11232
0.96
0.41
5.6
4.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
155
1440
1.08
0.41
2.3
2.2
ug/g
210.8
154.0
0.67
121
1119
(3019832) Treponema pallidum Ab [Presence] in Serum
63
558
1.13
0.41
1.6
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
7.2
—
0.3
—
0
17
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
204
1.23
0.40
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
204
1.23
0.40
1.3
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
54
474
1.14
0.40
1.7
1.6
—
—
—
0
0
(3001729) Color of Synovial fluid
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
72
645
1.12
0.39
3.2
3.4
ratio
2.0
1.8
—
7
47
(1617658) Protocol used for examination of sentinel lymph nodes
7
102
0.69
0.39
1.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
8
61
1.31
0.39
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
180
1921
0.93
0.39
4.6
3.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
97
1.34
0.39
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
90
990
0.91
0.39
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
665
0.88
0.39
1.1
1.3
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.3
—
62.2
—
0
8
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
44
382
1.15
0.38
3.1
3.3
u/ml
2276.9
1044.4
0.32
39
354
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
36
1.39
0.38
23.2
7.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
36
1.39
0.38
1.4
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
203
0.79
0.38
2.8
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
21
170
1.24
0.37
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
38
327
1.16
0.37
1.1
1.2
u/l
40.7
41.9
0.03
31
283
(3013139) Helicobacter pylori Ag [Presence] in Stool
102
938
1.09
0.35
1.3
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
42
1.43
0.35
1.5
2.9
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
99
1.31
0.35
1.8
1.5
u/l
6.3
8.2
—
8
49
(3042111) Morphology [Interpretation] in Bone marrow Narrative
40
348
1.15
0.34
2.3
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
30
351
0.85
0.34
1.0
1.1
—
—
—
0
0
(4034850)
45
510
0.88
0.34
17.5
12.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
118
1.27
0.33
1.0
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
669
6521
1.04
0.33
3.4
2.8
ug/l
154.9
153.8
0.03
601
5861
(3004588) Protein electrophoresis panel - Serum or Plasma
149
1398
1.07
0.33
2.1
2.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
210
1.19
0.32
1.4
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
119
1.26
0.31
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
110
1.27
0.31
4.6
3.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
30
348
0.86
0.31
2.0
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
75
685
1.10
0.31
2.6
3.1
u/ml
5615.3
6204.7
0.03
65
586
(3038515) Glucose [Moles/volume] in Venous blood
40
453
0.88
0.31
4.1
3.5
mmol/l
7.8
7.8
0.02
40
444
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
84
1.31
0.30
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
24
203
1.18
0.30
1.3
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
27
231
1.17
0.29
1.1
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
7
56
1.25
0.29
1.3
1.3
g/l
—
0.1
—
0
6
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
98
910
1.08
0.29
4.1
2.4
%
0.7
0.7
0.48
93
875
(3023410) Appearance of Cerebral spinal fluid
17
139
1.22
0.29
1.8
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
588
6027
0.97
0.28
5.0
4.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
85
786
1.08
0.28
2.1
2.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
112
1.25
0.28
1.1
1.1
u/ml
0.5
2.2
—
5
39
(3034860) Kappa light chains.free [Mass/volume] in Serum
72
661
1.09
0.28
3.2
3.4
mg/l
45.1
63.5
1.02
57
543
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
62
1.29
0.28
3.1
2.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
62
1.29
0.28
1.4
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
85
787
1.08
0.27
2.1
2.5
g/l
7.6
7.4
0.46
53
571
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
72
662
1.09
0.27
3.2
3.4
mg/l
84.6
83.1
0.01
57
546
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
290
0.86
0.27
1.6
1.3
—
—
—
0
0
(3019225) pH of Specimen
190
1811
1.05
0.27
4.2
4.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
31
271
1.15
0.27
2.5
3.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
26
300
0.87
0.27
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
214
2049
1.05
0.26
1.4
1.4
—
—
—
0
0
(4024509)
14
171
0.82
0.26
1.3
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
77
1.30
0.26
1.1
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
74
0.68
0.26
1.6
3.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
114
1.23
0.25
1.1
1.1
u/ml
4.1
5.3
—
5
50
(1002224) Polysomnography panel
36
403
0.89
0.25
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
105
1.24
0.24
1.1
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
20
234
0.85
0.24
1.4
1.8
pmol/l
200.3
213.0
0.32
20
218
(4306422)
19
161
1.18
0.24
1.4
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
384
3734
1.03
0.23
3.4
2.9
mosm/kgh2o
538.2
556.2
1.02
335
3172
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
785
1.07
0.23
2.1
2.5
g/l
3.7
3.9
0.41
52
551
(3021960) Folate [Moles/volume] in Serum or Plasma
431
4422
0.97
0.23
1.7
1.6
nmol/l
19.7
19.9
0.11
364
3730
(3004775) Volume in Urine collected for unspecified duration
12
146
0.82
0.22
1.8
2.2
ml
396.5
631.4
—
6
89
(3052592) Norovirus Ag [Presence] in Stool
5
41
1.22
0.22
1.2
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
14
167
0.84
0.21
1.5
1.3
e6/l
668898.8
85320.7
—
8
118
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
42
1.19
0.21
1.8
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.1
—
5.1
—
0
5
(3028717) Thiamine [Mass/volume] in Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
134
0.82
0.20
1.7
1.7
%
8.6
10.9
1.22
11
134
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
4221.3
—
0
8
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
27.2
—
0
14
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
48
1.25
0.20
1.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
49
1.23
0.20
1.5
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
15
127
1.18
0.19
2.9
3.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
52
1.15
0.19
1.8
3.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
58
1.21
0.18
1.1
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
43
396
1.09
0.18
4.3
2.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
14
119
1.18
0.17
9.6
2.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
18
157
1.15
0.17
1.6
1.2
u/ml
23.6
79.9
—
5
6
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
157
1.15
0.17
1.1
1.2
u/l
42.5
47.9
0.42
13
105
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50
537
0.93
0.17
2.1
2.5
g/l
0.0
0.0
0.00
41
484
(3051387) C reactive protein [Mass/volume] in Capillary blood
46
427
1.08
0.16
3.8
3.9
mg/l
34.0
29.0
0.30
28
287
(4281824)
18
158
1.14
0.16
1.1
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
72
1.11
0.16
1.4
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
187
1.12
0.15
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
56
526
1.07
0.15
3.1
3.1
nmol/l
0.8
0.8
0.65
48
414
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
741
1.05
0.15
2.2
2.5
g/l
10.0
10.4
0.30
60
618
(3006653) Thiamine [Moles/volume] in Blood
7
86
0.81
0.14
1.0
1.2
nmol/l
137.1
137.6
—
7
86
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
246
1.10
0.14
1.6
1.3
u/l
12.8
9.3
0.58
20
193
(40768804) Tissue Pathology biopsy report
625
6169
1.02
0.13
2.4
2.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
13
149
0.87
0.13
1.0
1.2
mmol/l
10.1
7.5
—
8
103
(3020876) Protein [Mass/time] in 24 hour Urine
17
151
1.13
0.13
1.8
1.9
—
1.3
—
0
5
(3017704) Immunofixation for Urine
15
132
1.14
0.13
1.1
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
54
571
0.94
0.13
2.1
2.4
g/l
0.0
0.0
1.70
45
515
(3020961) Endomysium IgA Ab [Titer] in Serum
50
530
0.94
0.13
1.1
1.1
—
192.8
—
0
11
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50
529
0.94
0.12
2.1
2.5
g/l
0.0
0.0
0.00
41
482
(3018095) Leukocytes [#/volume] in Urine
625
6176
1.02
0.12
4.9
3.9
e6/l
111.3
120.9
0.11
482
4597
(3044941) Cell count panel - Synovial fluid
29
268
1.08
0.12
1.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
40
377
1.06
0.11
2.1
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
415
4093
1.02
0.10
3.2
2.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
33
310
1.07
0.10
2.7
2.0
mmol/l
1.6
1.7
0.39
33
302
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
106
1.13
0.09
2.4
2.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
63
656
0.96
0.09
2.1
2.6
g/l
0.7
1.4
1.06
47
552
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
46
1.09
0.09
1.0
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
723
1.04
0.09
2.0
2.6
g/l
3.0
3.1
0.67
53
562
(3013826) Glucose [Moles/volume] in Serum or Plasma
1013
10065
1.01
0.09
6.3
4.9
mmol/l
6.8
6.9
0.54
961
9467
(3030467) Casts [#/volume] in Urine by Automated count
500
4946
1.01
0.09
4.1
3.3
e6/l
0.5
0.5
0.07
404
3846
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
94
969
0.97
0.09
2.5
2.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
49
468
1.05
0.09
1.7
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
19
206
0.92
0.08
1.5
1.6
%
70.5
65.0
0.29
14
136
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
56
1.07
0.08
1.5
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
918
9239
0.99
0.08
4.3
3.1
u/l
54.7
55.3
0.05
853
8397
(3021788) Differential panel - Synovial fluid
33
312
1.06
0.08
1.5
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
65
0.77
0.08
3.0
1.4
ug/l
8.1
8.2
—
5
56
(3026008) Bacteria identified in Urine by Culture
563
5581
1.01
0.08
4.0
3.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
67
692
0.97
0.07
2.3
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
143
0.91
0.07
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
143
0.91
0.07
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
108
1.11
0.07
1.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
20
186
1.08
0.07
1.5
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
81
0.86
0.07
1.1
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
81
0.86
0.07
1.1
1.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
7
82
0.85
0.07
2.1
1.6
nmol/l
11.4
16.6
—
7
73
(3009261) Glucose [Presence] in Urine by Test strip
782
7869
0.99
0.07
4.7
4.0
estimate
0.0
0.0
0.50
140
1426
(3026470) Cobalt [Mass/volume] in Blood
13
118
1.10
0.07
2.1
2.0
ug/l
4.1
3.0
0.45
13
103
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
9
86
1.05
0.07
3.3
3.3
u/l
241.3
214.8
—
9
86
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
144
1413
1.02
0.07
1.4
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
41
393
1.04
0.07
1.1
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
93
0.86
0.06
3.1
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
55
569
0.97
0.06
4.1
4.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
43
413
1.04
0.06
1.6
1.7
e6/l
8062.9
17915.2
1.65
27
305
(3002582) Erythrocytes [#/volume] in Urine
543
5471
0.99
0.06
4.3
3.5
e6/l
66.6
89.1
0.55
449
4317
(3024263) Appearance of Synovial fluid
9
102
0.88
0.06
1.1
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
399
4027
0.99
0.06
1.9
1.8
nmol/l
1141.1
1165.5
0.23
299
2979
(40768441) Liver Pathology biopsy report
10
111
0.90
0.06
1.4
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
217
1.06
0.06
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
159
1.07
0.05
1.2
1.2
nmol/l
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
110
0.91
0.05
1.5
1.3
—
—
—
0
0
(4268621)
12
110
1.09
0.05
2.7
2.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
25
238
1.05
0.05
1.2
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
780
7765
1.01
0.05
4.6
4.0
estimate
0.0
0.0
0.00
137
1467
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
34
353
0.96
0.04
1.5
1.2
u/ml
3.9
4.2
—
6
52
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
48
466
1.03
0.04
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
170
0.94
0.04
1.1
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
403
4006
1.01
0.03
1.7
1.7
pmol/l
16667116.5
12802656.3
0.08
312
3226
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
58
567
1.02
0.03
1.1
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
281
2789
1.01
0.03
1.3
1.2
u/ml
2.0
1.5
0.26
77
695
(36304419) Bacteria [Presence] in Urine
478
4760
1.01
0.03
4.2
3.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
18
188
0.96
0.02
2.3
2.0
u/field
4.0
2.4
—
9
65
(40760888) Immunoglobulin light chains.free panel - Serum
50
491
1.02
0.02
3.5
3.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
60
608
0.99
0.01
2.0
2.3
g/l
37.8
37.0
0.52
44
513
(3029937) Albumin [Presence] in Urine by Test strip
431
4317
1.00
0.00
5.2
4.3
estimate
0.0
0.0
0.50
127
1386
(3021601) Nitrite [Presence] in Urine by Test strip
777
7764
1.00
0.00
6.1
5.4
estimate
0.0
0.0
0.00
137
1466
(3051593) INR in Capillary blood by Coagulation assay
12
115
1.04
0.00
10.7
14.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
195
1.03
0.00
4.0
3.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
111
0.99
0.00
1.5
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
12
121
0.99
0.00
1.4
1.1
—
52.9
—
0
14
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
269
1.00
0.00
1.2
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
147
1471
1.00
0.00
4.2
3.7
mmol/l
1.2
1.2
0.25
129
1263
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
304
0.99
0.00
1.5
1.7
iu/l
2.7
5.0
—
9
98
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
168
1.01
0.00
1.3
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
25
248
1.01
0.00
1.5
1.2
u/ml
41.0
43.6
—
6
18
(3049717) Cytology report of Urine Cyto stain
87
868
1.00
0.00
3.6
2.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
347
3474
1.00
0.00
3.5
3.1
mmol/l
2.5
2.5
0.16
298
3005
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
74
743
1.00
0.00
1.2
1.2
iu/ml
116.1
131.9
0.13
25
265
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
58
0.86
0.00
1.4
2.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
6
67
0.90
0.00
1.8
2.3
e6/l
979.8
760.0
—
6
56
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
54
0.93
0.00
1.2
2.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
61
0.98
0.00
1.0
1.1
—
10.5
—
0
15
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
79
1.01
0.00
1.1
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
3.2
2.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
12
120
1.00
0.00
1.4
1.1
—
37.5
—
0
6
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
63
0.95
0.00
1.2
1.2
iu/ml
83.9
234.2
—
6
63
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
7
0.00
0.00
0.0
1.1
—
7.6
—
0
7
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
66
0.91
0.00
13.0
2.5
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
9
95
0.95
0.00
1.1
1.6
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
55
550
1.00
0.00
4.0
3.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.6
—
0
8
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
20
200
1.00
0.00
2.6
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
66
0.91
0.00
13.2
2.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
33.0
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.8
—
0
5
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint TBC_RESP and mortality.

Females

Parameter HR [95% CI] p-value
TBC_RESP 2.077 [1.85, 2.33] < 0.001
Birth year 0.996 [0.99, 1.0] 0.314

During the follow-up period (1.1.1998 — 31.12.2019), 1483 out of 2958 females with TBC_RESP died.

Males

Parameter HR [95% CI] p-value
TBC_RESP 2.815 [2.49, 3.19] < 0.001
Birth year 0.987 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 2702 out of 4601 males with TBC_RESP died.

Mortality risk

Mortality risk for people of age

years, who have TBC_RESP.

N-year risk Females Males
1 0.237% 0.513%
5 1.239% 3.228%
10 3.108% 7.591%
15 5.846% 14.501%
20 10.563% 23.591%

Relationships between endpoints

↥

Index endpoint: TBC_RESP – Respiratory tuberculosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data